Commonwealth Equity Services LLC raised its position in Perrigo Company plc (NYSE:PRGO – Free Report) by 5.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,927 shares of the company’s stock after purchasing an additional 2,365 shares during the period. Commonwealth Equity Services LLC’s holdings in Perrigo were worth $1,129,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the company. Cooke & Bieler LP lifted its stake in shares of Perrigo by 4.1% during the fourth quarter. Cooke & Bieler LP now owns 3,573,651 shares of the company’s stock valued at $91,879,000 after buying an additional 139,650 shares during the period. Wellington Management Group LLP lifted its stake in shares of Perrigo by 229.2% during the 3rd quarter. Wellington Management Group LLP now owns 2,697,698 shares of the company’s stock worth $70,761,000 after purchasing an additional 1,878,145 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Perrigo by 4.7% during the third quarter. Geode Capital Management LLC now owns 2,359,072 shares of the company’s stock worth $61,894,000 after purchasing an additional 106,356 shares during the last quarter. FMR LLC grew its position in shares of Perrigo by 66,795.3% in the third quarter. FMR LLC now owns 1,840,289 shares of the company’s stock valued at $48,271,000 after purchasing an additional 1,837,538 shares during the period. Finally, Bahl & Gaynor Inc. lifted its position in Perrigo by 44.9% during the fourth quarter. Bahl & Gaynor Inc. now owns 1,525,197 shares of the company’s stock worth $39,213,000 after buying an additional 472,958 shares during the period. 95.91% of the stock is owned by institutional investors and hedge funds.
Perrigo Stock Up 0.0 %
PRGO opened at $28.07 on Tuesday. The company has a market cap of $3.83 billion, a PE ratio of -23.99 and a beta of 0.48. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $33.46. The firm has a 50 day moving average price of $26.19 and a 200 day moving average price of $26.16.
Perrigo Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were paid a $0.29 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.13%. This is a positive change from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s dividend payout ratio (DPR) is -92.80%.
Insider Activity at Perrigo
In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the business’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the transaction, the executive vice president now owns 33,666 shares in the company, valued at $923,795.04. The trade was a 18.81 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.70% of the company’s stock.
Analyst Ratings Changes
Several analysts have commented on PRGO shares. Piper Sandler cut Perrigo from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $34.00 to $27.00 in a report on Monday, January 6th. Argus lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Finally, StockNews.com cut shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Perrigo has an average rating of “Hold” and a consensus price target of $33.00.
Read Our Latest Report on Perrigo
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Recommended Stories
- Five stocks we like better than Perrigo
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What Is WallStreetBets and What Stocks Are They Targeting?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How to Read Stock Charts for Beginners
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.